• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤患者中,DNAM-1 表达减少导致 γδ T 细胞细胞毒性降低。

Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients.

机构信息

Key Laboratory of Major Disease in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Beijing Key Laboratory for Genetics of Birth Defects, MOE Key Laboratory of Major Diseases in Children, Center for Medical Genetics, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.

Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.

出版信息

Clin Immunol. 2019 Jun;203:63-71. doi: 10.1016/j.clim.2019.04.006. Epub 2019 Apr 15.

DOI:10.1016/j.clim.2019.04.006
PMID:30999035
Abstract

Neuroblastoma is one of the children's malignant tumors with poor prognosis, as well as high recurrence and metastasis rates after surgical removal and chemotherapy. γδ T-cell based immunotherapy receives increasing attention thanks to the strong cytolytic activity to tumor cells. Our previous data revealed a significant increase in circulating γδ T-cell frequency in NB patients. In the present study, we found that beside a reduction of IFN-γ in serum of NB patients, DNAM-1 expression decreased in both circulating and PAM-expanded NB γδ T cells. Upon PAM stimulation, NB γδ T cells showed a reduced level of cell proliferation. In addition, the cytolytic activity of NB γδ T cells to NB cell lines was proved to be attenuated in a co-culture system. The fact that DNAM-1 neutralizing antibody abolished the tumor cell killing accentuates the indispensable role of DNAM-1 molecule in γδ T-cell cytolytic function.

摘要

神经母细胞瘤是一种预后不良的儿童恶性肿瘤,手术切除和化疗后复发和转移率较高。基于 γδ T 细胞的免疫疗法因其对肿瘤细胞的强烈细胞溶解活性而受到越来越多的关注。我们之前的数据显示,NB 患者循环 γδ T 细胞频率显著增加。在本研究中,我们发现除了 NB 患者血清中 IFN-γ 减少外,DNAM-1 在循环和 PAM 扩增的 NB γδ T 细胞中的表达也降低。在 PAM 刺激下,NB γδ T 细胞的细胞增殖水平降低。此外,在共培养系统中证实 NB γδ T 细胞对 NB 细胞系的细胞溶解活性减弱。DNAM-1 中和抗体消除肿瘤细胞杀伤的事实强调了 DNAM-1 分子在 γδ T 细胞细胞溶解功能中的不可或缺作用。

相似文献

1
Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients.神经母细胞瘤患者中,DNAM-1 表达减少导致 γδ T 细胞细胞毒性降低。
Clin Immunol. 2019 Jun;203:63-71. doi: 10.1016/j.clim.2019.04.006. Epub 2019 Apr 15.
2
Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.唑来膦酸使神经母细胞瘤来源的肿瘤起始细胞对人 γδ T 细胞介导的细胞溶解敏感。
J Immunother. 2012 Oct;35(8):598-606. doi: 10.1097/CJI.0b013e31826a745a.
3
Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.I型干扰素介导的唑来膦酸刺激外周血细胞扩增的γδT细胞抗白血病细胞毒性增强。
Cytotherapy. 2006;8(2):118-29. doi: 10.1080/14653240600620200.
4
Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.人源增殖γδ-T细胞对神经母细胞瘤的免疫反应表明Vδ1+亚群适用于基于γδ-T细胞的免疫疗法。
J Immunother. 2008 Nov-Dec;31(9):896-905. doi: 10.1097/CJI.0b013e31818955ad.
5
Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.人γδ T淋巴细胞对神经母细胞瘤细胞具有天然的和白细胞介素-2诱导的细胞毒性。
J Immunother. 2000 Sep-Oct;23(5):536-48. doi: 10.1097/00002371-200009000-00004.
6
Prospects for immunotherapy of acute myeloid leukemia using γδ T cells.使用γδ T细胞进行急性髓系白血病免疫治疗的前景。
Immunotherapy. 2017 Jan;9(2):111-114. doi: 10.2217/imt-2016-0139.
7
In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.脂质体阿仑膦酸盐与γδ T细胞免疫疗法联合应用于小鼠的体外效力、体外及体内疗效
J Control Release. 2016 Nov 10;241:229-241. doi: 10.1016/j.jconrel.2016.09.023. Epub 2016 Sep 21.
8
Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.外周血中固定化抗 TCRγδ抗体扩增的人γδ T 细胞过继免疫治疗肺癌。
Cancer Biol Ther. 2009 Aug;8(16):1540-9. doi: 10.4161/cbt.8.16.8950. Epub 2009 Aug 8.
9
DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.DNAX辅助分子-1(CD226)促进Vγ9Vδ2 T细胞对人肝癌细胞的裂解作用。
Eur J Immunol. 2009 May;39(5):1361-8. doi: 10.1002/eji.200838409.
10
Enhancement of anti-tumor cytotoxicity of expanded gammadelta T Cells by stimulation with monocyte-derived dendritic cells.通过单核细胞衍生的树突状细胞刺激增强扩增的γδ T细胞的抗肿瘤细胞毒性。
J Clin Exp Hematop. 2007 Nov;47(2):61-72. doi: 10.3960/jslrt.47.61.

引用本文的文献

1
The Immune Regulatory Functions of CD226 and Its Implications in Immune-Mediated Diseases.CD226的免疫调节功能及其在免疫介导疾病中的意义。
Biomolecules. 2025 Jul 14;15(7):1007. doi: 10.3390/biom15071007.
2
Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy.破坏γδT细胞激活受体与抑制受体之间的平衡以实现有效的癌症免疫治疗。
Nat Rev Cancer. 2025 Jun 2. doi: 10.1038/s41568-025-00830-x.
3
Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics.
揭开人类γδT细胞的奥秘:从起源到新型疗法。
Front Immunol. 2025 Apr 10;16:1543454. doi: 10.3389/fimmu.2025.1543454. eCollection 2025.
4
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.EphA2和磷酸抗原介导的γδT细胞对髓母细胞瘤的选择性杀伤可保持神经元和干细胞的完整性。
Oncoimmunology. 2025 Dec;14(1):2485535. doi: 10.1080/2162402X.2025.2485535. Epub 2025 Apr 7.
5
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma.阻断巨噬细胞移动抑制因子的分泌可增强嵌合抗原受体T细胞对神经母细胞瘤的疗效。
Eur J Cancer. 2025 Mar 11;218:115263. doi: 10.1016/j.ejca.2025.115263. Epub 2025 Jan 27.
6
Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments.癌症治疗中的γδ T细胞:从肿瘤识别到新型治疗方法
Front Med (Lausanne). 2024 Dec 19;11:1480191. doi: 10.3389/fmed.2024.1480191. eCollection 2024.
7
Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor-Ligand Interactions That Instructs Intratumoral γδT-cell Activity.空间和单细胞分析揭示了指导肿瘤内γδT细胞活性的DNAM-1受体-配体相互作用的异质性。
Cancer Res. 2025 Jan 15;85(2):277-298. doi: 10.1158/0008-5472.CAN-24-1509.
8
Controversial role of γδ T cells in colorectal cancer.γδ T细胞在结直肠癌中的争议性作用。
Am J Cancer Res. 2024 Apr 15;14(4):1482-1500. doi: 10.62347/HWMB1163. eCollection 2024.
9
CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells.CD155/PVR 决定 Delta One T 细胞对急性髓系白血病的靶向作用。
Blood. 2024 Apr 11;143(15):1488-1495. doi: 10.1182/blood.2023022992.
10
Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma.Nectin2 通过调节神经母细胞瘤中 ANXA2 的表达影响细胞凋亡。
Acta Biochim Biophys Sin (Shanghai). 2023 Mar 25;55(3):356-366. doi: 10.3724/abbs.2023020.